News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gonyer David A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 415,000 options to buy
@ $2.68, valued at
$1.1M
|
|
| 12/14/2020 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 48,046 shares
@ $2.9, valued at
$139.3k
Sold 23,954 shares
@ $2.94, valued at
$70.4k
|
|
| 12/11/2020 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Exercised 72,000 options to buy
@ $0.4, valued at
$28.8k
|
|
| 09/02/2020 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Acquired 20,238 shares
@ $1.05, valued at
$21.2k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Disposed/sold 85,000 options to buy
@ $3.07, valued at
$261k
Disposed/sold 70,687 options to buy
@ $3.04, valued at
$214.9k
Disposed/sold 60,000 options to buy
@ $3.04, valued at
$182.4k
Disposed/sold 225,000 options to buy
@ $2.36, valued at
$531k
Disposed/sold 225,000 options to buy
@ $2.43, valued at
$546.8k
Disposed/sold 225,000 options to buy
@ $2.94, valued at
$661.5k
Granted 63,750 options to buy
@ $0.62, valued at
$39.5k
Granted 53,015 options to buy
@ $0.62, valued at
$32.9k
Granted 45,000 options to buy
@ $0.62, valued at
$27.9k
Granted 168,750 options to buy
@ $0.62, valued at
$104.6k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2018 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Acquired 6,901 shares
@ $1.63, valued at
$11.2k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Gonyer David A (Director) has filed a Form 4 on SIGNAL GENETICS, INC. |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2016 |
4
| Gonyer David A (Director) has filed a Form 4 on SIGNAL GENETICS, INC.|
Txns:
| Granted 18,000 options to buy
@ $0.51, valued at
$9.2k
|
|
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2013 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 94,250 options to buy
@ $8.67, valued at
$817.1k
|
|
|
|